Skip to content

Comparison of misoprostol tablet given by sublingual and vaginal route in full term pregnant patients.

Efficacy of sublingual vs vaginal misoprostol tablet for induction of labour in term antenatal women : a randomized controlled trial. - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073480
Enrollment
100
Registered
2024-09-05
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O80- Encounter for full-term uncomplicated delivery

Interventions

Intervention1: Misoprostol tablet for induction of labour: Sublingually 25mcg misoprostol tablet will be given to 50 randomly selected term antenatal patients for induction of labour. Patient to be re

Sponsors

Deepakshi Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Singleton full term pregnancy with vertex presentation. Gravida 1 to 4 with clinically adequate pelvis Bishop score

Exclusion criteria

Exclusion criteria: Eclampsia Uncontrolled diabetes mellitus Women with previous cesarean section Hypersensitivity to misoprostol

Design outcomes

Primary

MeasureTime frame
To compare the efficacy of sublingual misoprostol tablet vs vaginal misoprostol tablet for induction of labour In terms of : Induction delivery interval Mode of delivery Timepoint: Improvement in Bishops score would be assessed every 4 hours. Maximum of 6 doses would be given. Further dosing would be stopped if patients Bishops score becomes more than 6.

Secondary

MeasureTime frame
To compare the side effects of tablet misoprostol in sublingual vs vaginal routeTimepoint: Side effects like nausea, vomiting, diarrhea , uterine tachysystole were identified. Every four hourly re-assessment is done to look for progress of labour.

Countries

India

Contacts

Public ContactDeepakshi Gupta

Lata Mangeshkar Hospital, Hingna, Nagpur

auttarwars@gmail.com8087079132

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026